Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Leticia Gomes de Pontes has a total of 150 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    EDUCAÇÃO EM SAÚDE NA ATENÇÃO PRIMÁRIA: ESTRATÉGIAS EDUCATIVAS PARA PROMOÇÃO DA SAÚDE, PREVENÇÃO DE DOENÇAS E ENGAJAMENTO COMUNITÁRIO

    by Leticia Gomes de Pontes, Mateus de Grise Barroso da Silva, Paulo Ricardo Gonçalves, Ana Izabel Ribeiro de Oliveira, Muriel Terra Pizzutti dos Santos, Georgenan Monteiro Silva dos Santos, Felipe de Assis Rocha Lima, Aparecido Francisco dos Reis, Everaldo dos Santos Mendes, Willker Menezes da Rocha

    A Atenção Primária à Saúde (APS) constitui a principal porta de entrada do sistema de saúde e desempenha papel central na coordenação do cuidado no território. Nesse contexto, a educação em saúde destaca-se como estratégia fundamental para promover o autocuidado, prevenir doenças e fortalecer a autonomia dos usuários. Este estudo tem como objetivo analisar o papel da educação em saúde na APS, com enfoque nas estratégias educativas voltadas à promoção da saúde, prevenção de doenças e fortalecimento do engajamento comunitário. Trata-se de uma revisão integrativa da literatura, realizada entre fevereiro e março de 2026, nas bases de dados MEDLINE e PubMed. Os resultados evidenciam que diferentes estratégias educativas contribuem para a promoção de hábitos saudáveis, fortalecimento do letramento em saúde, ampliação da participação social e qualificação das práticas profissionais. Conclui-se que a educação em saúde, quando desenvolvida de forma participativa e contextualizada, fortalece o engajamento comunitário e amplia a efetividade das ações de promoção da saúde na APS.


  • Open Access

    Zika Virus in Extracellular Vesicles: Insights from Integrated Proteomic and Metabolomic Dependent Regulation of B Cell and PI3K/AKT/mTOR Signaling Pathway

    by Leticia Gomes-De-Pontes, Lucila Akune Barreiros, Lillian Nunes Gomes, Ranieri Coelho Salgado, Sarah Maria da Silva Napoleão, Paulo V Soeiro-Pereira, Saulo Duarte Passos, Antonio Condino-Neto

    Background; Cell-released extracellular vesicles (EVs) acting as 'metabolically and proteolytically active machines,' show potential in metabolomic and proteomic analysis of serum EVs. Despite diverse challenges, post-isolation omics characterization EVs offers crucial insights for effective analysis; (2) Methods: The research, involved children with Congenital Zika Syndrome, utilizing mass spectrometry for proteomics and GC-MS for metabolite identification. Vesicles were isolated using Izon qEV columns, quantified, and characterized by NTA and TEM. Data analysis employed Cytoescape/String and MetaboAnalyst, revealing variations in metabolic and proteomic profiles among groups through PCA and volcano plots. Proteins and Metabolite set enrichment analysis provided biologically meaningful patterns to enriched metabolites; (3) Results: Using molecular exclusion chromatography, the EVs were characterized, revealing size variations. Protein analysis identified 13 significantly altered proteins, including upregulated (e.g., AOM8Q6 - IGLC7) and downregulated (e.g., Q8TD86 - CALML6) ones. Metabolite analysis indicated involvement in the PI3K-AKT-mTOR pathway and suggested a role in Angiotensin inhibition in CZS+. Upstream of mTOR, Akt is the central signaling molecule in the PI3K pathway and plays critical roles in brain development as well as synaptic plasticity important for Zika Virus. The study provides insights into molecular mechanisms associated with CZS; (4) Conclusions: The study pinpointed valuable possible biomarkers, specifically proteins and metabolites, in Zika virus (ZIKV) infection. It stresses the necessity for broader investigations with advanced techniques to uncover molecular targets, potentially advancing pharmacological strategies.

  • Open Access

    Photobiomodulation Reduces the Cytokine Storm Syndrome Associated with COVID-19 in the Zebrafish Model

    by Ivana F. Rosa, Ana P. B. Peçanha, Tábata R. B. Carvalho, Leonardo S. Alexandre, Vinícius G. Ferreira, Lucas B. Doretto, Beatriz M. Souza, Rafael T. Nakajima, Patrick da Silva, Ana P. Barbosa, et al.

    Although the exact mechanism of the pathogenesis of coronavirus SARS-CoV-2 (COVID-19) is not fully understood, oxidative stress and the release of pro-inflammatory cytokines have been highlighted as playing a vital role in the pathogenesis of the disease. In this sense, alternative treatments are needed to reduce the level of inflammation caused by COVID-19. Therefore, this study aimed to investigate the potential effect of red photobiomodulation (PBM) as an attractive therapy to downregulate the cytokine storm caused by COVID-19 in a zebrafish model. RT-qPCR analyses and protein–protein interaction prediction among SARS-CoV-2 and Danio rerio proteins showed that recombinant Spike protein (rSpike) was responsible for generating systemic inflammatory processes with significantly increased levels of pro-inflammatory (il1b, il6, tnfa, and nfkbiab), oxidative stress (romo1) and energy metabolism (slc2a1a and coa1) mRNA markers, with a pattern similar to those observed in COVID-19 cases in humans. On the other hand, PBM treatment was able to decrease the mRNA levels of these pro-inflammatory and oxidative stress markers compared with rSpike in various tissues, promoting an anti-inflammatory response. Conversely, PBM promotes cellular and tissue repair of injured tissues and significantly increases the survival rate of rSpike-inoculated individuals. Additionally, metabolomics analysis showed that the most-impacted metabolic pathways between PBM and the rSpike treated groups were related to steroid metabolism, immune system, and lipid metabolism. Together, our findings suggest that the inflammatory process is an incisive feature of COVID-19 and red PBM can be used as a novel therapeutic agent for COVID-19 by regulating the inflammatory response. Nevertheless, the need for more clinical trials remains, and there is a significant gap to overcome before clinical trials can commence.


  • Open Access

    Estudo proteômico do melasma facial

    by Luiza Vasconcelos Schaefer, Leticia Gomes de Pontes, Nayara Rodrigues Vieira Cavassan, Lucilene Delazari dos Santos, Hélio Amante Miot

  • Open Access

    Proteomic study of facial melasma

    by Luiza Vasconcelos Schaefer, Leticia Gomes de Pontes, Nayara Rodrigues Vieira Cavassan, Lucilene Delazari dos Santos, Hélio Amante Miot


  • Open Access

    Photobiomodulation reduces the cytokine storm syndrome associated with Covid-19 in the zebrafish model

    by Ives Charlie-Silva, Ana Barbosa, Letícia De Pontes, Camila Bomfim, Glaucia Machado-Santelli, Antonio Condino-Neto, Cristiane Guzzo, Jean Schatzmann Peron, Renata Medeiros, Fausto Ferraris, et al.

    This work presents the first study showing how photobiomodulation (PBM) significantly increases cellular and tissue repair and elucidating the role of PBM with low-level laser as a possible new therapy in pathologies in COVID-19-associated cytokine storm syndrome from a zebrafish model. Our results demonstrate new strategies for treating SARS-COV-2 using PBM to modulate the expression of the genes and metabolites involved in inflammatory processes. These metabolic alterations show that the r-Spike led to disturbance in the energetic and inflammatory system, corroborating with the severe clinical conditions of human patients. Furthermore, PBM decreased the gene expression levels of pro-inflammatory cytokines such as il1b, il6, tnfa, and nfkbiab, and of factors involved in oxidative stress (romo1) and energy metabolism (slc2a1a, coa1), in various tissues, promoting an anti-inflammatory response. In summary, our study suggests that PBM may have a positive role in treating cytokine storm syndrome associated with COVID-19. PBM can significantly regulate the inflammatory response promoting cellular and tissue repair of injured tissues. This work suggests that PBM may have a positive role in treating COVID-19-associated cytokine storm syndrome. Nevertheless, the need for more clinical trials remains, and there is a significant gap to overcome before clinical trials.

  • Open Access

    Zebrafish studies on the vaccine candidate to COVID-19, the Spike protein: Production of antibody and adverse reaction

    by Bianca H Ventura Fernandes, Natália Martins Feitosa, Ana Paula Barbosa, Camila Gasque Bomfim, Anali M. B. Garnique, Francisco I. F. Gomes, Rafael T. Nakajima, Marco A. A. Belo, Silas Fernandes Eto, Dayanne Carla Fernandes, et al.

    Summary: Establishing new experimental animal models to assess the safety and immune response to the antigen used in the development of COVID-19 vaccine is an imperative issue. Based on the advantages of using zebrafish as a model in research, herein we suggest doing this to test the safety of the putative vaccine candidates and to study immune response against the virus. We produced a recombinant N-terminal fraction of the Spike SARS-CoV-2 protein and injected it into adult female zebrafish. The specimens generated humoral immunity and passed the antibodies to the eggs. However, they presented adverse reactions and inflammatory responses similar to severe cases of human COVID-19. The analysis of the structure and function of zebrafish and human Angiotensin-converting enzyme 2, the main human receptor for virus infection, presented remarkable sequence similarities. Moreover, bioinformatic analysis predicted protein-protein interaction of the Spike SARS-CoV-2 fragment and the Toll-like receptor pathway. It might help in the choice of future therapeutic pharmaceutical drugs to be studied. Based on the in vivo and in silico results presented here, we propose the zebrafish as a model for translational research into the safety of the vaccine and the immune response of the vertebrate organism to the SARS-CoV-2 virus.


  • Open Access

    Extracellular vesicles in infectious diseases caused by protozoan parasites in buffaloes

    by Leticia Gomes de Pontes, Wanessa Fernanda Altei, Asier Galan, Petra Bilić, Nicolas Guillemin, Josipa Kuleš, Anita Horvatić, Lígia Nunes de Morais Ribeiro, Eneida de Paula, Virgínia Bodelão Richini Pereira, et al.

    Keywords: Extracellular vesicles; Theileria spp.; Protozoan parasites; Nanoparticle tracking analysis; Proteomic analysis


  • Occupational allergy in the handling of snakes from the Center for Studies of Venom and Venomous Animals CEVAP/UNESP

    by Nayara Rodrigues Vieira Cavassan, Letícia Gomes De Pontes, Laudicéia Alves De Oliveira, Ćaio Cavassan, Cristina Maria Kokron, Keity Souza Santos, Daniele Danella Figo, Benedito Barraviera, Rui Seabra Ferreira Júnior, Elaine Gagete, et al.

  • Correlation between chronic venous ulcer exudate proteins and clinical profile: A cross-sectional study

    by Nayara Rodrigues Vieira Cavassan, Caio Cavassan Camargo, Letícia Gomes de Pontes, Benedito Barraviera, Rui Seabra Ferreira, Hélio Amante Miot, Luciana Patrícia Fernandes Abbade, Lucilene Delazari dos Santos